PHAR
Pharming Group N.V. 9/4/2025, 10:38:18 AM
NasdaqGM
USD
EQUITY
At Close
$14.36
+0.35 (+2.50%)
Volume
8,651
+13.6% vs 3M Avg
Market Cap
983.87M
NasdaqGM
Period
No AI Analysis Available
Generate a comprehensive AI analysis for PHAR to get insights on valuation, growth prospects, and investment recommendations.
Valuation
-
-
Profitability
-3.7%
2.8%
3.5%
89.3%
5.8%
-2.4%
Growth
22.4%
18.9%
-
-
-
Financial Health
Forward Looking
Strong Buy
$30.00
-
$-1.64
Small-Cap
Risk & Technical
0.54
$17.08 / $6.73
62.57
0.0%
Shareholder Returns
-
-
-
-1.5%
3.0%